Feb. 28, 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Sanjeev Luther, President and CEO, to provide corporate overview and business outlook
Feb. 27, 2026
Relay Therapeutics to Announce Q4 and Full Year 2025 Results
The biotech company will report its latest financial performance next week.
Feb. 27, 2026
EverQuote Reports Record Q4 and Full-Year 2025 Results
Insurer expects 'stable and healthy' P&C market in 2026 as it accelerates AI adoption
Feb. 24, 2026
Akamai Earnings Expected to Rise as Analysts Revise Forecasts
Akamai partners with Visa to enhance identity verification and security for e-commerce
Feb. 15, 2026
Safehold Reports Strong Q4 Earnings, Outlines 2026 Priorities
REIT sees momentum coming out of 2025, plans higher origination volume and greater visibility into Caret's value
Feb. 14, 2026
Pegasystems Highlights Strong Q4, Guides for Continued Growth in 2026
Cloud adoption and AI-powered Blueprint product drive momentum for software company
Feb. 14, 2026
Forrester Research Focuses on AI as Revenue Declines
Company plans to rebrand flagship AI tool, exit strategy consulting, and shift events model amid restructuring.
Feb. 12, 2026
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
PYRUKYND® (mitapivat) worldwide net revenues of $54.0 million for full year; AQVESME™ (mitapivat) for thalassemia now available in U.S. following FDA approval
Feb. 9, 2026
ProQR Announces Planned Changes to Board Composition
Two board members to rotate off as company advances clinical programs and focuses on long-term succession planning.
